by RJ Shara | Jun 25, 2021 | Startups
A number of customized health tech start-ups intend to reinvent take care of patients struggling with musculoskeletal (MSK) medical conditions and persistent discomfort. The buzzy yet powerful framing is growing in popularity among Silicon Valley start-ups. These conditions are commonly treated with addictive opioids, a major public health issue.”Frequently it’s not brand-new ideas, it’s conflating a number of aspects that come together at one minute in time that permit exponential change that makes a startup work,” Melton stated, of the boom and current activity in MSK medicine. Clearing provides 4 products: prescription substance cream that includes FDA-approved active ingredients, CBD cream for topical pain, nutraceuticals to supplement joint health, and a directory site of prerecorded, at-home workouts. 
…
by RJ Shara | Jun 17, 2021 | Startups
Jonathan Bush, the CEO and co-founder of Athenahealth, is a controversial figure in the questionable field of healthcare. More than 20 years after he began the now-public health care business, Bush lost Athenahealth to Elliott Management, an activist investor that bought the business together with Veritas Capital. During this tense time period, domestic violence claims appeared […] More than 2 decades after he began the now-public healthcare business, Bush lost Athenahealth to Elliott Management, an activist financier that purchased the business alongside Veritas Capital. Now, Bush is back once again, this time as the co-founder of a new start-up that aims to re-invent the digital health data stack.”These digital health companies will largely not work if they aren’t significantly accelerated,” he said. 
…
by RJ Shara | Apr 30, 2021 | Fundings and Exit, Startups
Hi and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unload the numbers behind the headlines. First and foremost, Equity was nominated for a Webby for”Best Technology Podcast”! Drop whatever and go Vote for Equity! We ‘d appreciate it . A lot. And even if we lose, well, we’ll keep doing
our thing and making each […]
Equity was chosen for a Webby for” Best Innovation Podcast”! Drop whatever and go Vote for Equity!.?. …
by RJ Shara | Apr 7, 2021 | Startups
Healthcare insurance, if you’re fortunate to have it, only covers a subset of conditions in the United States. As an outcome, clients can typically get burdened with horror story charges, like big deductibles, out-of-network costs and costly co-pays. So for the insured and uninsured alike, ingenious methods of managing huge expenses remain in high demand [ …]
Walnut uses a “buy now, pay later” design, promoted by Affirm and Klarna, to assist patients pay for health care over a period of time, instead of in one $3,000 chunk. It’s a sweet offer, but Patel included one more detail that he thinks makes Walnut stand out: The startup doesn’t charge any interest or fees to customers. Now, preferably, a supplier would desire to get 100%of payments they are owed, however that is wishful thinking. Patel says that Walnut just accepted a portion of these applications, however decreased to share what percent of cash it has actually lent so far. …
by RJ Shara | Apr 1, 2021 | Startups
Numerous business needed to adjust throughout the COVID-19 pandemic. For SOSV-backed Achiko, this suggested moving its focus from mobile payment services to cost effective COVID-19 screening. Achiko’s platform integrates an app called Teman Sehat (“Health Buddy” in Indonesian) for payments and keeping test records, and exclusive affordable screening packages utilizing DNA aptamers, or artificial strands of […] The app provides rewards for individuals to get tested, take payments and keep records of test results that could be used for check-ins by companies and offices. While working on Teman Sehat, nevertheless, Goh said Achiko’s group understood that the cost of COVID-19 PCR and rapid tests were too high for lots of individuals in emerging markets. Achiko’s group highlights it is not meant to be a replacement for PCR and quick tests. Procurement and manufacturing for Aptamex tests is presently underway in Taiwan, and Achiko is preparing filings with Indonesia’s Ministry of Health with the target of shipping sets by the start of the 3rd quarter. For SOSV-backed Achiko, this implied shifting its focus from mobile payment services to economical COVID-19 screening….
by RJ Shara | Mar 26, 2021 | Startups
Lively, a medical innovation business that’s established a non reusable vibrating pill to treat chronic irregularity, today announced its Series E for $7.5 million. The company is based in Tel Aviv and is lead by Lior Ben-Tsur, a start-up veteran. Considering that its founding in 2007, the company has raised an overall of $25 million. This round […] In addition to being medication-free, the value of Lively over laxatives, according to the company, is that the bowel movements are more regulated, whereas laxatives can cause unanticipated diarrhea and long-lasting side impacts. In a 2019 human trial organized by Lively, 250 patients were registered in a double-blind study (Dynamic Capsule = 133, placebo = 117). According to Ben-Tsur, there hasn’t been any advancement in the treatment of constipation in the last 20 years– the treatment procedure has continued to focus on medication. The business is presently speaking with healthcare providers and insurance coverage companies so that the capsule will be covered by insurance beginning at the time of launch. 
…
by RJ Shara | Mar 2, 2021 | Startups
SpineZone is a startup that develops customized workout programs and treatment for neck and pain in the back. The company utilizes an online platform and in-person centers to deliver a curriculum that, ideally, helps patients avoid the requirement for prescription surgeries, drugs and injections, and providers then avoid the expense of all of the above. Co-founded by […] SpineZone’s value proposal is that it assists payers and companies, whether that be employers, clinics or health plans such as Cigna or Aetna, avoid positioning their clients in surgical treatments, which are costly. If SpineZone guarantees to get a center to $12 million in invest from $15 million, and the cost ends up being $17 million, the company will pay the center a portion of the distinction. SpineZone joins a cohort of health tech start-ups that focus on musculoskeletal conditions. In order to win, lots of startups, SpineZone consisting of, need value-based care to replace fee-for-service care. …
by RJ Shara | Dec 4, 2020 | Fundings and Exit, Startups
OTV (formerly called Olive Tree Ventures), an Israeli venture capital company that concentrates on digital health tech, announced it has actually closed a brand-new fund amounting to $170 million. The company likewise launched a brand-new workplace in Shanghai, China to spearhead its growth in the Asia Pacific region. OTV presently has an overall of 11 business […] Jose Antonio Urrutia Rivas will serve as OTV’s Head of Asia Pacific, managing its Shanghai office and helping its portfolio business broaden in China and other Asian nations. OTV was established in 2015 by general partners Mayer Gniwisch, Amir Lahat and Alejandro Weinstein. …
Recent Comments